Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
April 15, 2024 07:00 ET
|
Ocular Therapeutix, Inc.
BEDFORD, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through...
Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
February 22, 2024 07:30 ET
|
Ocular Therapeutix, Inc.
Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific Officer, Peter K. Kaiser, MD to be Medical Director, and Sanjay...
AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
October 10, 2023 01:00 ET
|
AstriVax
Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles at GSK Vaccines.Barbara Freitag joins AstriVax as an accomplished CFO in the biotech...
Intravitreal Injectables Global Market Report 2022: Excellent Biocompatibility and Impressive Pharmacodynamic Properties Drive Adoption
January 25, 2023 09:58 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors
July 07, 2022 08:00 ET
|
Eyenovia, Inc.
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™)...
Worldwide Ophthalmology Industry to 2027 - Surge in Research and Development to Provide New Treatment Presents Opportunities
January 18, 2022 05:08 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology Market Research Report by Diseases, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been...
AGTC Announces Two Key Leadership Team Appointments
October 14, 2021 17:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
Adverum Appoints CMO and CSO
June 01, 2021 08:00 ET
|
Adverum Biotechnologies, Inc.
-- Julie Clark, M.D., appointed chief medical officer -- -- Brigit Riley, Ph.D., appointed chief scientific officer – REDWOOD CITY, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Adverum...
Financial Projections of the Peptides & Macrocycle Drug Discovery Services & Platforms Market; 2020 through 2030
May 19, 2020 04:13 ET
|
Research and Markets
Dublin, May 19, 2020 (GLOBE NEWSWIRE) -- The "Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030" report has been added to ResearchAndMarkets.com's ...
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
March 08, 2019 07:00 ET
|
Eloxx Pharmaceuticals
Eloxx announces the hiring of Dr. Susan Schneider as SVP Ophthalmology to lead the development of its rare inherited retinal disease programs Abstract accepted for presentation at European Cystic...